Cassava Sciences in the NEWS  Cassava Sciences, Inc. (SAVA) announced that it entered into an agreement …

Verona Pharma Conference Announcements Verona Pharma (VRNA) announces that senior management will present a company overview …

Alnylam Pharmaceuticals Questions & Answers Q: Why has Alnylam Pharmaceuticals’ stock plummeted recently? A: We do …

Sanofi A scheduled review of the E.mbrace phase 3 study (clinical trial identifier: NCT04899336) conducted by …

Boehringer Ingelheim Today, Boehringer Ingelheim, a private Company announced that the FIBRONEER™-ILD trial met its primary …

Supernus Pharmaceuticals Supernus Pharmaceuticals (SUPN) - a biopharmaceutical company focused on developing products for the treatment …

Vertex Pharmaceuticals Yesterday, January 30, 2025, Vertex Pharmaceuticals (VRTX) announced FDA approval of journavx™(suzetrigine), a First-in-Class …

Akero Therapeutics Full Press Release Following our shortened report earlier today, this posting is from the …

Vera Therapeutics in the Market Today Today, many investors in the biotechnology market caused a selloff …

Halozyme Therapeutics Today, January 8, 2025 /PRNewswire/ - Halozyme Therapeutics, Inc. (HALO) provided a financial update, …